Impulse Dynamics® Presented Real-World, Late-Breaking Data Revealing Heart Failure Hospitalization Reduction and Sustained Clinical Benefits of CCM® Therapy at One Year

Impulse Dynamics ® Presented Real-World, Late-Breaking Data Revealing Heart Failure Hospitalization Reduction and Sustained Clinical Benefits of CCM ® Therapy at One Year U.S. Post-Approval Study Results Presented at Heart Failure Society of America Annual Meeting MARLTON, N.J., October 11th, 2026 (GLOBE NEWSWIRE) — Impulse Dynamics ® , a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced late-breaking, one-year clinical outcomes from its U.S. Post-Approval Study of CCM ® Therapy presented at the Heart Failure Society of America (H